Thus, the exact crosstalk between FOXO3, autophagy, and sorafenib resistance in HCC remains fully unclear and needs to be further and consistently studied, especially using adequate sorafenib-resistant HCC in vitro models and exploring tumor cell response under normal oxygen conditions. This evidence concerns the gene FOXO3 and neoplasm.